Table 2.
Characteristics of patients according to neoadjuvant chemoradiotherapy
| Characteristic | No NACRT | NACRT | P valueb |
|---|---|---|---|
| Age (years)a | 66 (20) | 64.0 (12.5) | 0.740 |
| Sex (% male) | 66.2% | 70.4% | 0.588 |
| Distance between the tumor and the anus (cm)a | 10 (6) | 7 (5) | < 0.001 |
| Number of lymph nodes harvesteda | 14 (8) | 10.0 (7.5) | < 0.001 |
| Number of metastatic lymph nodesa | 1 (3) | 0 (0) | < 0.001 |
| Lymph node ratioa | 0.06 (0.24) | 0 (0) | < 0.001 |
| Patients without metastatic lymph nodes (%) | 46.5% | 80.3% | < 0.001 |
| Patients with disease relapse (%) | 26.8% | 19.7% | 0.320 |
| Time to relapse (months)a | 19 (8) | 13 (18) | 0.223 |
| Disease-free survival interval (months)a | 47 (42) | 34 (42) | 0.548 |
NACRT neoadjuvant chemoradiotherapy
aResults are reported as median (interquartile range)
bP values < 0.05 are reported in bold